Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-24-000146

Co-Chief Executive Officer acquired 315,681 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-03 Option exercise : show line 1 in the form +315,681 $1.58 $498,776 10,199,776 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-03 Option exercise : show line 2 in the form Warrant (right to buy) −315,681 0 I
Loading xslF345X05/wk-form4_1727988861.xml…